Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993:45 Suppl 3:98-101.
doi: 10.2165/00003495-199300453-00017.

Fluoroquinolones in the treatment of cystic fibrosis

N Høiby  1 , S S Pedersen, T Jensen, N H Valerius, C Koch
Affiliations
Review

Fluoroquinolones in the treatment of cystic fibrosis

N Høiby et al. Drugs. 1993.

Abstract

Cystic fibrosis patients suffer from recurrent and chronic lung infections mainly caused by Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa. The fluoroquinolones, notably ciprofloxacin and ofloxacin, represent an important addition to the therapy of P. aeruginosa infections. They offer the possibility of effective oral treatment for early colonisation as well as chronic infections, even in children. They are associated with only few and mild adverse effects. Development of resistance represents an increasing problem.

PubMed Disclaimer

References

    1. J Int Med Res. 1990;18 Suppl 4:27D-36D - PubMed
    1. J Antimicrob Chemother. 1990 Jun;25(6):995-1010 - PubMed
    1. Antimicrob Agents Chemother. 1991 Aug;35(8):1538-46 - PubMed
    1. Eur J Clin Microbiol. 1987 Dec;6(6):618-22 - PubMed
    1. Acta Pathol Microbiol Immunol Scand B. 1987 Aug;95(4):227-32 - PubMed

MeSH terms